3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid TumorsDisease Attributes, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Thoracic Neoplasms, adenocarcinoma, adenoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, connective tissue neoplasm, epithelial neoplasm, lung disorder, lung neoplasm, malignant mesothelioma, mesothelial neoplasm, mesothelioma, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, pleural neoplasm, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, sarcoma, small cell lung carcinoma, synovial sarcomaRecruitingPhase 12026-10-01NCT07713732
Pan Tumor Rollover Studycancer, neoplasmRecruitingPhase 22026-09-23NCT03899155
A Study to Evaluate Long-term Safety of Zanubrutinib Regimens in Participants With B-Cell Malignancies Who Participated in BeiGene Parent Studies of ZanubrutinibB-cell MalignanciesActive, not recruitingPhase 32026-08-28NCT04170283